23andMe Investor Day Presentation Deck slide image

23andMe Investor Day Presentation Deck

Using Genetics to Inform Clinical Development Jennifer Low, M.D., Ph.D. Head of Therapeutics Development Copyright © 2022 23andMe, Inc. 23andMe 49
View entire presentation